Retinis Pigmentosa (RP) includes a group of progressive hereditary retinal diseases involving degeneration of rod and cone photoreceptors, predominantly the former, and is one of the leading causes of hereditary blindness in the developed world. Clinical symptoms include nyctalopia, progressive visual field loss, and deterioration in visual acuity in adolescence. It affects one in 3000-5000 individuals and can be caused by mutations in more than 40 genes. In addition, Retinitis Pigmentosa may exist either alone (nonsyndromic) or as part of a neurological or systemic disorder, such as Ushers syndrome and Infantile Refsums disease. There are few effective clinical treatments for retinitis pigmentosa which affects an estimated 1.5 million individuals world-wide. However, understanding the histopathologic changes occurring in RP is critical to understanding the rationale for current therapies, as well as to develop future therapies. This book highlights the most recent research done in the field.
Preface; Experimental Therapy for Retinitis Pigmentosa; Retinitis Pigmentosa; Great Expectations:: RPE65 Mutations in South Africa; Diagnosis and Treatment of Retinitis Pigmentosa Based on the Pathology; Mutational Analysis of RHO and RDS Genes in Patients with Retinitis Pigmentosa from Volga-Ural Region of Russia; Physiopathology of Retinal Degeneration in Rd1 Mouse Model of Retinitis Pigmentosa:: TGF-B1, Proteinases & Oxidative Stress Mechanisms; Visual Training in Retinitis Pigmentosa Patients:: Neural Plasticity & Function Recovery; Index.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.